A phosphotyrosine switch regulates organic cation transporters
Authors:
Open Access
- 16 March 2016
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 10880
Abstract
Membrane transporters are key determinants of therapeutic outcomes. They regulate systemic and cellular drug levels influencing efficacy as well as toxicities. Here we report a unique phosphorylation-dependent interaction between drug transporters and tyrosine kinase inhibitors (TKIs), which has uncovered widespread phosphotyrosine-mediated regulation of drug transporters. We initially found that organic cation transporters (OCTs), uptake carriers of metformin and oxaliplatin, were inhibited by several clinically used TKIs. Mechanistic studies showed that these TKIs inhibit the Src family kinase Yes1, which was found to be essential for OCT2 tyrosine phosphorylation and function. Yes1 inhibition in vivo diminished OCT2 activity, significantly mitigating oxaliplatin-induced acute sensory neuropathy. Along with OCT2, other SLC-family drug transporters are potentially part of an extensive ‘transporter-phosphoproteome’ with unique susceptibility to TKIs. On the basis of these findings we propose that TKIs, an important and rapidly expanding class of therapeutics, can functionally modulate pharmacologically important proteins by inhibiting protein kinases essential for their post-translational regulation.Keywords
This publication has 71 references indexed in Scilit:
- PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouseNucleic Acids Research, 2011
- Probing cellular protein complexes using single-molecule pull-downNature, 2011
- Membrane transporters in drug developmentNature Reviews Drug Discovery, 2010
- A chemical and phosphoproteomic characterization of dasatinib action in lung cancerNature Chemical Biology, 2010
- Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin-Induced NephrotoxicityClinical Pharmacology & Therapeutics, 2009
- PROMALS3D: a tool for multiple protein sequence and structure alignmentsNucleic Acids Research, 2008
- Subunit counting in membrane-bound proteinsNature Methods, 2007
- Statistical potential for assessment and prediction of protein structuresProtein Science, 2006
- MUSCLE: multiple sequence alignment with high accuracy and high throughputNucleic Acids Research, 2004
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993